Matches in SemOpenAlex for { <https://semopenalex.org/work/W4298333802> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- W4298333802 endingPage "1, 83" @default.
- W4298333802 startingPage "80" @default.
- W4298333802 abstract "Biosimilar drug regulatory status, created in 2004 for copies of biological drugs, is far more onerous than generic drug status. The possibility of substituting a cheaper copy for an originator drug once its market monopoly has expired has major implications for the efficient management of healthcare expenditure.The context surrounding the creation of the concept of biosimilarity was one of originator pharmaceutical companies trying to defend their turf by preventing copies of biotechnology-derived drugs from acquiring the status of generics. While generic drugs are authorised on the basis of an abridged application, companies that wish to market a copy of a biotechnology-derived drug must provide the results of specific preclinical tests and clinical trials.The reasons put forward are, in particular, technical difficulties in establishing the similarity of complex biological substances. In May 2013, the European Medicines Agency (EMA) released for public consultation a draft revision of its guidelines on the evaluations required to obtain marketing authorisation for copies of biological drugs.This EMA proposal would relax a number of requirements that are of little value to patients and delay the market introduction of these copies. In late 2014 and early 2015, the EMA adopted the final version of these guidelines. The response of the Medicines in Europe Forum and the International Society of Drug Bulletins (ISDB) to this consultation provided an opportunity to review the current situation regarding biosimilars, ten years after this regulatory status was created. These two international networks supported the EMA's pragmatic proposals to no longer require that clinical trials be routinely conducted before biosimilar drugs can be authorised. This response also provided an opportunity to stress that unless a difference in efficacy or adverse effects is demonstrated, assigning a different international nonproprietary name (INN) from that of the originator drug would lead to a profusion of names for the same drug and cause unnecessary confusion for healthcare professionals and patients." @default.
- W4298333802 created "2022-10-02" @default.
- W4298333802 date "2015-03-01" @default.
- W4298333802 modified "2023-10-18" @default.
- W4298333802 title "Biosimilars: towards fewer obstacles to their use." @default.
- W4298333802 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25897464" @default.
- W4298333802 hasPublicationYear "2015" @default.
- W4298333802 type Work @default.
- W4298333802 citedByCount "0" @default.
- W4298333802 crossrefType "journal-article" @default.
- W4298333802 hasConcept C100001284 @default.
- W4298333802 hasConcept C108170787 @default.
- W4298333802 hasConcept C108759981 @default.
- W4298333802 hasConcept C111472728 @default.
- W4298333802 hasConcept C112930515 @default.
- W4298333802 hasConcept C126322002 @default.
- W4298333802 hasConcept C138885662 @default.
- W4298333802 hasConcept C142724271 @default.
- W4298333802 hasConcept C144133560 @default.
- W4298333802 hasConcept C151730666 @default.
- W4298333802 hasConcept C155202549 @default.
- W4298333802 hasConcept C162324750 @default.
- W4298333802 hasConcept C162853370 @default.
- W4298333802 hasConcept C2777589142 @default.
- W4298333802 hasConcept C2778917124 @default.
- W4298333802 hasConcept C2779343474 @default.
- W4298333802 hasConcept C2781127519 @default.
- W4298333802 hasConcept C2985089533 @default.
- W4298333802 hasConcept C34447519 @default.
- W4298333802 hasConcept C38652104 @default.
- W4298333802 hasConcept C41008148 @default.
- W4298333802 hasConcept C59491497 @default.
- W4298333802 hasConcept C60644358 @default.
- W4298333802 hasConcept C71924100 @default.
- W4298333802 hasConcept C75480439 @default.
- W4298333802 hasConcept C86803240 @default.
- W4298333802 hasConceptScore W4298333802C100001284 @default.
- W4298333802 hasConceptScore W4298333802C108170787 @default.
- W4298333802 hasConceptScore W4298333802C108759981 @default.
- W4298333802 hasConceptScore W4298333802C111472728 @default.
- W4298333802 hasConceptScore W4298333802C112930515 @default.
- W4298333802 hasConceptScore W4298333802C126322002 @default.
- W4298333802 hasConceptScore W4298333802C138885662 @default.
- W4298333802 hasConceptScore W4298333802C142724271 @default.
- W4298333802 hasConceptScore W4298333802C144133560 @default.
- W4298333802 hasConceptScore W4298333802C151730666 @default.
- W4298333802 hasConceptScore W4298333802C155202549 @default.
- W4298333802 hasConceptScore W4298333802C162324750 @default.
- W4298333802 hasConceptScore W4298333802C162853370 @default.
- W4298333802 hasConceptScore W4298333802C2777589142 @default.
- W4298333802 hasConceptScore W4298333802C2778917124 @default.
- W4298333802 hasConceptScore W4298333802C2779343474 @default.
- W4298333802 hasConceptScore W4298333802C2781127519 @default.
- W4298333802 hasConceptScore W4298333802C2985089533 @default.
- W4298333802 hasConceptScore W4298333802C34447519 @default.
- W4298333802 hasConceptScore W4298333802C38652104 @default.
- W4298333802 hasConceptScore W4298333802C41008148 @default.
- W4298333802 hasConceptScore W4298333802C59491497 @default.
- W4298333802 hasConceptScore W4298333802C60644358 @default.
- W4298333802 hasConceptScore W4298333802C71924100 @default.
- W4298333802 hasConceptScore W4298333802C75480439 @default.
- W4298333802 hasConceptScore W4298333802C86803240 @default.
- W4298333802 hasIssue "158" @default.
- W4298333802 hasLocation W42983338021 @default.
- W4298333802 hasOpenAccess W4298333802 @default.
- W4298333802 hasPrimaryLocation W42983338021 @default.
- W4298333802 hasRelatedWork W2057101259 @default.
- W4298333802 hasRelatedWork W2073019919 @default.
- W4298333802 hasRelatedWork W2105106235 @default.
- W4298333802 hasRelatedWork W2148713084 @default.
- W4298333802 hasRelatedWork W2320776272 @default.
- W4298333802 hasRelatedWork W2804129635 @default.
- W4298333802 hasRelatedWork W2903995216 @default.
- W4298333802 hasRelatedWork W3115615542 @default.
- W4298333802 hasRelatedWork W3123944830 @default.
- W4298333802 hasRelatedWork W4205537124 @default.
- W4298333802 hasVolume "24" @default.
- W4298333802 isParatext "false" @default.
- W4298333802 isRetracted "false" @default.
- W4298333802 workType "article" @default.